These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 22719911)

  • 21. Malaria case-management under artemether-lumefantrine treatment policy in Uganda.
    Zurovac D; Tibenderana JK; Nankabirwa J; Ssekitooleko J; Njogu JN; Rwakimari JB; Meek S; Talisuna A; Snow RW
    Malar J; 2008 Sep; 7():181. PubMed ID: 18803833
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Health facility and health worker readiness to deliver new national treatment policy for malaria in Kenya.
    Njogu J; Akhwale W; Hamer DH; Zurovac D
    East Afr Med J; 2008 May; 85(5):213-21. PubMed ID: 18814531
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The magnitude and trend of artemether-lumefantrine stock-outs at public health facilities in Kenya.
    Sudoi RK; Githinji S; Nyandigisi A; Muturi A; Snow RW; Zurovac D
    Malar J; 2012 Feb; 11():37. PubMed ID: 22316236
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Home management of malaria with artemether-lumefantrine compared with standard care in urban Ugandan children: a randomised controlled trial.
    Staedke SG; Mwebaza N; Kamya MR; Clark TD; Dorsey G; Rosenthal PJ; Whitty CJ
    Lancet; 2009 May; 373(9675):1623-31. PubMed ID: 19362361
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A randomized, open-label, comparative efficacy trial of artemether-lumefantrine suspension versus artemether-lumefantrine tablets for treatment of uncomplicated Plasmodium falciparum malaria in children in western Kenya.
    Juma EA; Obonyo CO; Akhwale WS; Ogutu BR
    Malar J; 2008 Dec; 7():262. PubMed ID: 19102746
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The feasibility, patterns of use and acceptability of using mobile phone text-messaging to improve treatment adherence and post-treatment review of children with uncomplicated malaria in western Kenya.
    Otieno G; Githinji S; Jones C; Snow RW; Talisuna A; Zurovac D
    Malar J; 2014 Feb; 13():44. PubMed ID: 24490872
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Malaria management-progress made and challenges still to face.
    Ogutu BR
    Malar J; 2009 Oct; 8 Suppl 1(Suppl 1):S1. PubMed ID: 19818168
    [No Abstract]   [Full Text] [Related]  

  • 28. Impact of the large-scale deployment of artemether/lumefantrine on the malaria disease burden in Africa: case studies of South Africa, Zambia and Ethiopia.
    Barnes KI; Chanda P; Ab Barnabas G
    Malar J; 2009 Oct; 8 Suppl 1(Suppl 1):S8. PubMed ID: 19818175
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A qualitative study of the feasibility and community perception on the effectiveness of artemether-lumefantrine use in the context of home management of malaria in south-west Nigeria.
    Ajayi IO; Falade CO; Olley BO; Yusuf B; Gbotosho S; Iyiola T; Olaniyan O; Happi C; Munguti K; Pagnoni F
    BMC Health Serv Res; 2008 Jun; 8():119. PubMed ID: 18513447
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Development of a text-messaging intervention to improve treatment adherence and post-treatment review of children with uncomplicated malaria in western Kenya.
    Githinji S; Jones C; Malinga J; Snow RW; Talisuna A; Zurovac D
    Malar J; 2015 Aug; 14():320. PubMed ID: 26283229
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pyronaridine-artesunate or dihydroartemisinin-piperaquine versus current first-line therapies for repeated treatment of uncomplicated malaria: a randomised, multicentre, open-label, longitudinal, controlled, phase 3b/4 trial.
    West African Network for Clinical Trials of Antimalarial Drugs (WANECAM)
    Lancet; 2018 Apr; 391(10128):1378-1390. PubMed ID: 29606364
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Community case management of fever due to malaria and pneumonia in children under five in Zambia: a cluster randomized controlled trial.
    Yeboah-Antwi K; Pilingana P; Macleod WB; Semrau K; Siazeele K; Kalesha P; Hamainza B; Seidenberg P; Mazimba A; Sabin L; Kamholz K; Thea DM; Hamer DH
    PLoS Med; 2010 Sep; 7(9):e1000340. PubMed ID: 20877714
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The Impact of an Intervention to Improve Malaria Care in Public Health Centers on Health Indicators of Children in Tororo, Uganda (PRIME): A Cluster-Randomized Trial.
    Staedke SG; Maiteki-Sebuguzi C; DiLiberto DD; Webb EL; Mugenyi L; Mbabazi E; Gonahasa S; Kigozi SP; Willey BA; Dorsey G; Kamya MR; Chandler CIR
    Am J Trop Med Hyg; 2016 Aug; 95(2):358-367. PubMed ID: 27273646
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Deploying artemether-lumefantrine with rapid testing in Ethiopian communities: impact on malaria morbidity, mortality and healthcare resources.
    Lemma H; Byass P; Desta A; Bosman A; Costanzo G; Toma L; Fottrell E; Marrast AC; Ambachew Y; Getachew A; Mulure N; Morrone A; Bianchi A; Barnabas GA
    Trop Med Int Health; 2010 Feb; 15(2):241-50. PubMed ID: 19961564
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The clinical efficacy of artemether/lumefantrine (Coartem).
    Makanga M; Krudsood S
    Malar J; 2009 Oct; 8 Suppl 1(Suppl 1):S5. PubMed ID: 19818172
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Health workers perceptions on chloroquine and sulfadoxine/sulfalene pyrimethamine monotherapies: implications for the change to combination therapy of artemether/lumefantrine in Tanzania.
    Tarimo DS; Malekela DA
    East Afr J Public Health; 2007 Apr; 4(1):43-6. PubMed ID: 17907761
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Measurement of adherence, drug concentrations and the effectiveness of artemether-lumefantrine, chlorproguanil-dapsone or sulphadoxine-pyrimethamine in the treatment of uncomplicated malaria in Malawi.
    Bell DJ; Wootton D; Mukaka M; Montgomery J; Kayange N; Chimpeni P; Hughes DA; Molyneux ME; Ward SA; Winstanley PA; Lalloo DG
    Malar J; 2009 Aug; 8():204. PubMed ID: 19709418
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Perceptions and utilization of the anti-malarials artemether-lumefantrine and dihydroartemisinin-piperaquine in young children in the Chikhwawa District of Malawi: a mixed methods study.
    Ewing VL; Terlouw DJ; Kapinda A; Pace C; Richards E; Tolhurst R; Lalloo DG
    Malar J; 2015 Jan; 14():13. PubMed ID: 25605477
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Exploring provider and community responses to the new malaria diagnostic and treatment regime in Solomon Islands.
    Wijesinghe RS; Atkinson JA; Bobogare A; Wini L; Whittaker M
    Malar J; 2011 Jan; 10():3. PubMed ID: 21219614
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Provider knowledge of treatment policy and dosing regimen with artemether-lumefantrine and quinine in malaria-endemic areas of western Kenya.
    Watsierah CA; Onyango RO; Ombaka JH; Abong'o BO; Ouma C
    Malar J; 2012 Dec; 11():436. PubMed ID: 23273046
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.